Atea Pharmaceuticals (AVIR) Non-Current Assets (2019 - 2026)
Atea Pharmaceuticals' Non-Current Assets was $3.62 million in Q2 2026, down 39.7% from $6 million a year earlier and down 6.8% from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Non-Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Atea Pharmaceuticals came in at $4.23 million, up 82.7% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $2.31 million in FY2024 (-48.7%), $4.51 million in FY2023 (-22.0%), $5.79 million in FY2022 and $489,000 in FY2021 (+215.5%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q4 2024.
- Compared with a year earlier, Non-Current Assets was higher in four of the last eight quarters, with growth averaging 13.3%.
- The best year-over-year quarter for Non-Current Assets over five years was Q3 2022 (growth of 731.7%); the worst was Q3 2021 (a decline of 67.0%).
- Per Business Quant data, AVIR's Non-Current Assets in the three quarters before Q2 2026 was $3.88 million (Q1 2026), $4.23 million (Q4 2025) and $6.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Atea Pharmaceuticals | 337.28 Mn | -631.22 Mn | - | 438,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 438,000.00 |
| Jun 30, 2026 | 3.62 Mn |
| Mar 31, 2026 | 3.88 Mn |
| Dec 31, 2025 | 4.23 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.26 Mn |
| Dec 31, 2024 | 2.31 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 4.02 Mn |
| Mar 31, 2024 | 4.27 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 4.76 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 5.74 Mn |
| Dec 31, 2022 | 5.79 Mn |
| Sep 30, 2022 | 4.64 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 3.96 Mn |
| Dec 31, 2021 | 489,000.00 |
API Access
Atea Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();